Innovation
V4Cure: snake venom to treat kidneys
… rodents to validate the toxin's biological activity. "I demonstrated the efficacy of this molecule in treating kidney … was to find a pharmaceutical company capable of taking his active ingredient and developing it. He worked with a … out phase III trials and bring the drug to market by 2032," comments Nicolas Gilles. Although the original toxin comes …Published on: